Early identification and management of graft failure after unrelated cord blood transplantation

Bone Marrow Transplantation

Volumn 42, Issue 1, 2008, Pages 35-41

  Chan, K W ^a,b   Grimley, M S ^a,b   Taylor, C ^a,b   Wall, D A ^a,b  

^a TEXAS TRANSPLANT INSTITUTE   (United States)

^b Methodist Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; CYCLOSPORIN A; FLUDARABINE; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BK VIRUS; CANCER MORTALITY; CANCER SURVIVAL; CANDIDA; CHILD; CHILDHOOD LEUKEMIA; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CONVALESCENCE; CORD BLOOD STEM CELL TRANSPLANTATION; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DONOR; EARLY DIAGNOSIS; EARLY INTERVENTION; ENGRAFTMENT; EPSTEIN BARR VIRUS; FANCONI ANEMIA; FEMALE; GRAFT FAILURE; GRAFT INFECTION; HEMATOPOIESIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HLA MATCHING; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NEUTROPHIL COUNT; NOCARDIA; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PSEUDOMONAS; SEPSIS; SEVERE COMBINED IMMUNODEFICIENCY; STOMATITIS; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 48949116758     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.40     Document Type: Article

References (29)

1. Rubinstein P, Carrier C. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Clin Haematol 2000; 13: 565-584.
2. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NKC et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802.
3. Thompson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-2711.
4. Kernan NA, Carter SL, Wagner JE, Baxter-Lowe L, Wall D, Kapoor N et al. Umbilical cord blood transplantation in pediatric patients: results of the prospective, multi-institutional cord blood transplantation study (COBLT). Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 14 (abst 33).
5. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A et al Unrelated donor cord blood transplantation for childhood acute myeloid leukemia: A Eurocord Group analysis. Blood 2003; 102 4290-4297.
6. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-260.
7. Ohwada C, Nakaseko C, Ozawa S, Takeuchi M, Shono K, Koizumi M et al Second cord blood transplantation with reduced-intensity conditioning for graft failure after first CBT for AML. Bone Marrow Transplant 2004; 34: 999-1000.
8. Fernandes J, Rocha V, Robin M, Peffault de Latour R, Traineau R, Devergie A et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007; 137: 248-251.
9. Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T. Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85-87. April 23 (e-pub ahead of print).
10. Narimatsu H, Kami M, Miyakoshi S, Murashige N, Yuji K, Hamaki T et al Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2005; 132: 36-41.
11. Shimada K, Narimatsu H, Morishita Y, Kohno A, Saito S, Kato Y. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006; 37: 787-788.
12. Davies S, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsey NKC et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 73-77.
13. Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al Second early allogeneic stem cell transplantation for graft failure in acute leukemia, chronic myeloid leukemia and aplastic anemia. Br J Haematol 2000; 111: 292-302.
14. Remberger M, Ringden O, Ljungman P, Hagglund H, Winiarski J, Lonnqvist B et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73-78.
15. Grandage VL, Cornish JM, Pamphilon DH, Potter MN, Steward CG, Oakhill A et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 1998; 21: 687-690.
16. Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplant 1986; 1: 21-30.
17. Wolff SN. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545-552.
18. Barker JN, Weisdorf DJ, DeFor TE, Blazer BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
19. Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: Impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362-370.
20. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002; 100: 2005-2011.
21. Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la Camara R et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: Comparison of cord blood transplantation with peripheral blood and marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734-748.
22. Barker JN, Martin PL, Coad JE, DeFor TE, Trigg ME, Kurtzberg J et al Low incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395-399.
23. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymo-cyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874-2880.
24. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al Chronic graft-versus-host disease in children: Incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192-1200.
25. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954-1963.
26. Antin JH, Childs R, Filipovich AH, Giralt S, MacKinnon S, Spitzer T et al. Biol Blood Marrow Transplant 2001; 7: 473-485.
27. Bader P, Holle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: The impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant 1997; 19: 697-702.
28. Cimino G, Rapanotti MC, Elia L, Lori AP, Gugliemi C, Screnci M et al A prospective molecular study of chimerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: Detection of mixed chimerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. Br J Haematol 1999; 104: 770-777.
29. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher incidence of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 1986; 67: 811-816.